- $13.22m
- -$14.85m
- 25
- 49
- 80
- 50
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 11.1 | 14.1 | 13.9 | 17.3 | 20 |
Operating Profit | -11.1 | -14.1 | -13.9 | -17.3 | -20 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -10.6 | -13.8 | -13.8 | -17.2 | -19.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -10.6 | -13.8 | -13.8 | -17.2 | -19.1 |
Net Income Before Extraordinary Items | |||||
Net Income | -10.6 | -13.8 | -13.8 | -17.2 | -19.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -10.6 | -13.8 | -13.8 | -17.2 | -19.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -52.2 | -693 | -9.12 | -83.1 | -3.37 |